Rockefeller Capital Management L.P. Adaptive Biotechnologies Corp Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$3.46 - $5.33 $150,907 - $232,467	-43,615 Reduced 36.22%	76,798 $376,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $165,626 - $275,717	-32,668 Reduced 21.34%	120,413 $656,000
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $73,493 - $104,244	-11,873 Reduced 7.2%	153,081 $1.03 Million
Q1 2023 May 17, 2023	SELL	$7.8 - $10.11 $12,558 - $16,277	-1,610 Reduced 0.97%	164,954 $1.46 Million
Q4 2022 Mar 06, 2023	SELL	$6.26 - $9.34 $66,036 - $98,527	-10,549 Reduced 5.96%	166,564 $1.27 Million
Q3 2022 Nov 02, 2022	SELL	$6.5 - $12.67 $69,862 - $136,177	-10,748 Reduced 5.72%	177,113 $1.26 Million
Q2 2022 Aug 12, 2022	SELL	$6.4 - $14.73 $249 - $574	-39 Reduced 0.02%	187,861 $1.52 Million
Q1 2022 May 13, 2022	BUY	$10.12 - $28.9 $228,023 - $651,174	22,532 Added 13.63%	187,900 $2.61 Million
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $843,874 - $1.24 Million	33,527 Added 25.43%	165,368 $4.64 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $111,884 - $148,595	3,727 Added 2.91%	131,841 $4.48 Million
Q2 2021 Aug 10, 2021	SELL	$32.22 - $44.59 $17.8 Million - $24.6 Million	-551,449 Reduced 81.15%	128,114 $5.23 Million
Q1 2021 May 11, 2021	BUY	$37.26 - $67.74 $23.8 Million - $43.3 Million	638,841 Added 1568.79%	679,563 $27.4 Million
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $790,465 - $1.15 Million	17,562 Added 75.83%	40,722 $2.41 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $519,670 - $708,721	14,520 Added 168.06%	23,160 $1.13 Million
Q2 2020 Aug 12, 2020	BUY	$24.95 - $48.38 $119,760 - $232,224	4,800 Added 125.0%	8,640 $418,000
Q1 2020 May 12, 2020	BUY	$16.96 - $34.16 $55,086 - $110,951	3,248 Added 548.65%	3,840 $107,000
Q4 2019 Feb 07, 2020	SELL	$24.56 - $32.8 $9,406 - $12,562	-383 Reduced 39.28%	592 $18,000
Q3 2019 Nov 12, 2019	BUY	$30.31 - $53.51 $29,552 - $52,172	975 New	975 $30,000

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$178 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$85.5 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$69.3 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$68.9 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$63.2 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account